• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年百日咳免疫接种的影响,2004-2009:来自澳大利亚的经验教训。

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

机构信息

National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, NSW, Australia.

出版信息

Bull World Health Organ. 2011 Sep 1;89(9):666-74. doi: 10.2471/BLT.11.086538. Epub 2011 Jul 5.

DOI:10.2471/BLT.11.086538
PMID:21897487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3165977/
Abstract

OBJECTIVE

To compare the impact of three strategies for delivering a booster dose of adult-formulated tetanus-diphtheria-pertussis (Tdap) vaccine to adolescents in Australia. These comprise: (i) administering Tdap to: a one-year age cohort; (ii) administering Tdap to the entire high school and to subsequent entrant cohorts; and (iii) administering Tdap to the entire high school but without continuing to immunize entrant cohorts.

METHODS

A series of ecologic analyses of pertussis notifications during epidemic periods in relevant age cohorts were conducted. The primary outcome measure was the incidence rate ratio (IRR), calculated by dividing pertussis incidence after the introduction of Tdap delivery programmes by pertussis incidence during the most recent pre-programme epidemic.

FINDINGS

During the epidemic period of 2008-2009, the national-level IRR among age cohorts targeted for Tdap was 0.6 (95% confidence interval, CI: 0.6-0.7), but among other age cohorts it was 1.1 (95% CI: 1.1-1.2). Only the jurisdiction that implemented strategy 2 (Western Australia) experienced sustained decreases in pertussis notifications in both adolescents and infants under 6 months of age (IRR: 0.4; 95% CI: 0.3-0.6) until 2009.

CONCLUSION

If confirmed by longer experience in Australia and elsewhere, a broad school-based catch-up programme followed by immunization of school entrants may be the optimum strategy for the implementation of adolescent Tdap programmes.

摘要

目的

比较澳大利亚为青少年接种成人配方白喉-破伤风-百日咳(Tdap)疫苗加强针的三种策略的影响。这些策略包括:(i)为一年龄组接种 Tdap;(ii)为整个高中及后续入学队列接种 Tdap;(iii)为整个高中接种 Tdap,但不再为入学队列接种。

方法

对相关年龄队列在流行期间百日咳发病情况进行了一系列生态学分析。主要观察指标是发病率比值比(IRR),通过将 Tdap 接种项目引入后的百日咳发病率除以最近一次流行前的百日咳发病率来计算。

结果

在 2008-2009 年的流行期间,目标接种 Tdap 的年龄组的全国性 IRR 为 0.6(95%置信区间,CI:0.6-0.7),但其他年龄组的 IRR 为 1.1(95% CI:1.1-1.2)。只有实施策略 2(西澳大利亚州)的司法管辖区在青少年和 6 个月以下婴儿的百日咳发病率均持续下降(IRR:0.4;95% CI:0.3-0.6),直到 2009 年。

结论

如果在澳大利亚和其他地方有更长的经验证实,广泛的基于学校的追赶计划,随后对入学学生进行免疫接种可能是实施青少年 Tdap 计划的最佳策略。

相似文献

1
The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.青少年百日咳免疫接种的影响,2004-2009:来自澳大利亚的经验教训。
Bull World Health Organ. 2011 Sep 1;89(9):666-74. doi: 10.2471/BLT.11.086538. Epub 2011 Jul 5.
2
Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.青少年百日咳加强剂量对加拿大不列颠哥伦比亚省和魁北克省百日咳发病率的影响。
Vaccine. 2020 Jan 16;38(3):427-432. doi: 10.1016/j.vaccine.2019.10.063. Epub 2019 Nov 1.
3
Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018.澳大利亚疫苗可预防疾病流行病学综述系列:百日咳,2013-2018 年。
Commun Dis Intell (2018). 2022 Jan 27;46. doi: 10.33321/cdi.2022.46.3.
4
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.评估破伤风白喉无细胞百日咳联合疫苗(Tdap)预防百日咳的效果:免疫迅速衰减的证据以及 Tdap 品牌效力的差异。
J Infect Dis. 2014 Sep 15;210(6):942-53. doi: 10.1093/infdis/jiu322. Epub 2014 Jun 5.
5
Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.1995 - 2005年十年间澳大利亚的百日咳流行病学——按地区和年龄组划分的趋势
Commun Dis Intell Q Rep. 2007 Jun;31(2):205-15. doi: 10.33321/cdi.2007.31.18.
6
Acellular pertussis vaccine for adolescents.青少年用无细胞百日咳疫苗。
J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S15-24. doi: 10.2223/JPED.1491. Epub 2006 Jun 16.
7
Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.荷兰的一项开放标签、平行、随机对照试验:母亲百白破疫苗接种及其对 12 个月以下婴儿免疫应答的影响。
Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.
8
Using computer simulations to compare pertussis vaccination strategies in Australia.利用计算机模拟比较澳大利亚的百日咳疫苗接种策略。
Vaccine. 2004 Jun 2;22(17-18):2181-91. doi: 10.1016/j.vaccine.2003.11.053.
9
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
10
A "new age" in pertussis prevention new opportunities through adult vaccination.百日咳预防的“新时代”:成人接种疫苗带来的新机遇
Am J Prev Med. 2007 Mar;32(3):177-185. doi: 10.1016/j.amepre.2006.10.015.

引用本文的文献

1
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.百日咳的再度流行:流行病学趋势、致病机制及预防策略。
Front Immunol. 2025 Jul 10;16:1618883. doi: 10.3389/fimmu.2025.1618883. eCollection 2025.
2
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.终身预防百日咳的现状与未来展望:基于土耳其地区视角的叙述性综述
Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10.
3
Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe.学龄儿童、青少年及成人中的百日咳博德特氏菌:欧洲流行病学与死亡率的系统评价
Infect Dis Ther. 2021 Dec;10(4):2071-2118. doi: 10.1007/s40121-021-00520-9. Epub 2021 Aug 26.
4
Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.学龄儿童、青少年及成人中的百日咳博德特氏菌:亚洲地区流行病学、疾病负担及死亡率的系统评价
Infect Dis Ther. 2021 Sep;10(3):1115-1140. doi: 10.1007/s40121-021-00439-1. Epub 2021 Apr 29.
5
Comparative genomics of whole-cell pertussis vaccine strains from India.印度全细胞百日咳疫苗株的比较基因组学研究。
BMC Genomics. 2020 May 7;21(1):345. doi: 10.1186/s12864-020-6724-8.
6
A Vaccine Against Cervical Cancer: Context for the Global Public Health Practitioner.宫颈癌疫苗:全球公共卫生从业者的背景。
Glob Health Sci Pract. 2018 Dec 27;6(4):629-634. doi: 10.9745/GHSP-D-18-00222.
7
The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of .黏膜免疫、鼻咽部携带、无症状传播与……的复发之间的关系
F1000Res. 2017 Aug 25;6:1568. doi: 10.12688/f1000research.11654.1. eCollection 2017.
8
Risk factors for pertussis in adults and teenagers in England.英国成人和青少年患百日咳的风险因素。
Epidemiol Infect. 2017 Apr;145(5):1025-1036. doi: 10.1017/S0950268816002983. Epub 2017 Jan 9.
9
Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.博德特氏菌腺苷酸环化酶毒素与丝状血凝素相互作用以抑制体外生物膜形成。
Mol Microbiol. 2017 Jan;103(2):214-228. doi: 10.1111/mmi.13551. Epub 2016 Nov 3.
10
Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations.改善青少年免疫接种可及性和覆盖率干预措施的系统评价与Meta分析
J Adolesc Health. 2016 Oct;59(4S):S40-S48. doi: 10.1016/j.jadohealth.2016.07.005.

本文引用的文献

1
School-based vaccination in NSW.新南威尔士州的校内疫苗接种
N S W Public Health Bull. 2010 Sep-Oct;21(9-10):237-42. doi: 10.1071/NB10046.
2
Immunisation coverage annual report, 2008.《2008年免疫接种覆盖率年度报告》
Commun Dis Intell Q Rep. 2010 Sep;34(3):241-58.
3
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.十年一次给予低含量抗原的白喉破伤风类毒素和无细胞百日咳疫苗在年轻人中的效果。
Clin Infect Dis. 2010 Sep 15;51(6):656-62. doi: 10.1086/655825.
4
Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 - conclusions and recommendations.免疫战略咨询专家组会议,2010年4月——结论与建议
Wkly Epidemiol Rec. 2010 May 28;85(22):197-212.
5
National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.2008年美国13至17岁青少年的全国、州和地方疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001.
6
Pertussis vaccine effectiveness after mass immunization of high school students in Australia.澳大利亚高中生大规模免疫接种后的百日咳疫苗效力
Pediatr Infect Dis J. 2009 Feb;28(2):152-3. doi: 10.1097/INF.0b013e318185608e.
7
Vaccination coverage among adolescents aged 13-17 years - United States, 2007.2007年美国13至17岁青少年的疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3.
8
A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.西北地区百日咳发病率比较:儿童和青少年接种全细胞百白破疫苗前后。
Can J Infect Dis Med Microbiol. 2005 Sep;16(5):271-4. doi: 10.1155/2005/642315.
9
Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.1995 - 2005年十年间澳大利亚的百日咳流行病学——按地区和年龄组划分的趋势
Commun Dis Intell Q Rep. 2007 Jun;31(2):205-15. doi: 10.33321/cdi.2007.31.18.
10
Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting.百日咳的预防:来自第二届全球百日咳倡议圆桌会议的建议。
Vaccine. 2007 Mar 30;25(14):2634-42. doi: 10.1016/j.vaccine.2006.12.017. Epub 2006 Dec 22.